A Phase 3, Randomized Study of Nivolumab plus Ipilimumab in Combination with Chemotherapy vs Chemotherapy alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC)
| Title | A Phase 3, Randomized Study of Nivolumab plus Ipilimumab in Combination with Chemotherapy vs Chemotherapy alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC) |
|---|---|
| Description | The study will submit its CSR data to Health Authority of some areas.and foreign countries. |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA011385 |
| Release Date | 2022-12-31 |
| Submitter | nan zhao (1165095416@qq.com) |
| Organization | Jilin Cancer Hospital |
| Submission Date | 2022-11-30 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX002479-01 | CA209-9LA Backup Dataset | 227 | Biomarker Data | 7.1 MB | zip | 0 | Controlled |